Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Genome-Wide Association Study Identifies Variation in ABO As Risk Factor for Platelet Reactivity in Heparin-Induced Thrombocytopenia

Jason B Giles, Jérôme Rollin, PhD, Christian M Shaffer, Heidi E Steiner, Yukihide Momozawa, DVM,PhD, Ian Stanaway, PhD, Taisei Mushiroda, Claire Pouplard, PharmD, PhD, Nancy Heddle, MSc, Michiaki Kubo, MDPhD, Elizabeth Phillips, MD, Theodore E. Warkentin, MD, Yves Gruel, MD PhD, Andreas Greinacher, MD, Dan Roden, MD, Jason Karnes, PhDPharmD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-139651

Published: 2020

Journal Articles

Is There an Alternative to Serotonin Release Assay for the Diagnosis of Heparin Induced Thrombocytopenia (HIT)? Evaluation of 5 Other Functional Methods Using 5B9 a Monoclonal IgG That Mimics HIT Human Antibodies

Eve-Anne Guéry, PharmD, Caroline Vayne, PharmD, Cloé Derray, Joévin Besombes, Wayne Corentin Lambert, Jérôme Rollin, PhD, Yves Gruel, MD PhD, Claire Pouplard, PharmD, PhD

Blood (2018) 132 (Supplement 1): 3742.

https://doi.org/10.1182/blood-2018-99-115011

Published: 2018

Journal Articles

Cleavage of Anti-PF4/H IgG Antibodies By Ides, and Potential Benefit in the Treatment of Heparin-Induced Thrombocytopenia

Claire Kizlik-Masson, Quentin Deveuve, Yuhang Zhou, MD PhD, Caroline Vayne, PharmD, Gilles Thibault, PharmD, PhD, Steven Edward McKenzie, MD PhD, Claire Pouplard, PharmD, PhD, Stéphane Loyau, Jérôme Rollin, PhD, Yves Gruel, MD PhD

Blood (2018) 132 (Supplement 1): 518.

https://doi.org/10.1182/blood-2018-99-114450

Published: 2018

Journal Articles

Frequency of Anti-PF4/Heparin Antibodies in Patients Treated with Extra-Corporeal Membrane Oxygenation and Detection By Sensitized Serotonin Release Assay of Pathogenic Heparin-Induced Thrombocytopenia Antibodies

Caroline Vayne, PharmD, Marc-Antoine May, MD, Thierry Bourguignon, MD PhD, Eric Lemoine, MD, Eve-Anne Guéry, PharmD, Jérôme Rollin, PhD, Yves Gruel, MD PhD, Claire Pouplard, PharmD, PhD

Blood (2018) 132 (Supplement 1): 1143.

https://doi.org/10.1182/blood-2018-99-114571

Published: 2018

Journal Articles

Multicenter Pharmacokinetic Evaluation of rFVIII-Fc (Elocta) in a Real Life and Comparison with Non-Extended Half-Life FVIII Concentrates

Claire Pouplard, PharmD, PhD, Laurent Sattler, Anne Ryman, Valérie Eschwege, Emmanuel De Maistre, Claire Flaujac, Jean Szymezak, François Grand, Yohann Repesse, Hubert Galinat, Magali Donnard, Catherine Ternisien, Emmanuelle Jeanpierre

Blood (2018) 132 (Supplement 1): 1196.

https://doi.org/10.1182/blood-2018-99-110036

Published: 2018

Journal Articles

Prospective Evaluation of a Rapid Nanoparticle-Based Lateral Flow Immunoassay (Stic Expert HIT ® ) for the Diagnosis of Heparin-Induced Thrombocytopenia

Claire Pouplard, PharmD, PhD, Dorothee Leroux, PharmD, Nathalie Hezard, MD, PhD, Aurelien Lebreton, MD, Anne Bauters, MD, William Cohen, Emmanuel De Maistre, MD, Isabelle Diaz, Pharm D, Marie-Genevieve Huisse, Catherine Ternisien, MD, Sophie Voisin, MD, Yves Gruel, MD, PhD

Blood (2012) 120 (21): 1087.

https://doi.org/10.1182/blood.V120.21.1087.1087

Published: 2012

Journal Articles

Incidence of Antibodies to Protamine/Heparin Complexes in Cardiac Surgery Patients and Impact on Platelet Activation in Vitro and Clinical Outcome

Claire Pouplard, PharmD, PhD, Dorothee Leroux, PharmD, Jerôme Rollin, PhD, Amiral Jean, PhD, May Marc Antoine, MD, Aupart Michel, MD, Yves Gruel, MD, PhD

Blood (2011) 118 (21): 2217.

https://doi.org/10.1182/blood.V118.21.2217.2217

Published: 2011

Journal Articles

Interleukin-10 Promoter Microsatellite Polymorphisms Influence the Immune Response to Heparin and the risk of Heparin-Induced Thrombocytopenia.

Claire Pouplard, PharmD, PhD, Pascale Cornillet-Lefebvre, PharmD, PhD, Redha Attaoua, PharmD, PhD, Dorothee Leroux, PharmD, Florin Grigorescu, MD, PhD, Carinne Lecoq-Lafon, Jerôme Rollin, PhD, Philippe Nguyen, MD, PhD, Yves Gruel, MD

Blood (2010) 116 (21): 3682.

https://doi.org/10.1182/blood.V116.21.3682.3682

Published: 2010

Journal Articles

Influence of Protein Tyrosine Phosphatase Polymorphisms on the Development of Antibodies to Platelet Factor 4 and the Risk of Heparin-Induced Thrombocytopenia.

Jerôme Rollin, PhD, Claire Pouplard, PharmD, PhD, Dorothee Leroux, PharmD, Marc-Antoine May, MD, Yves Gruel, MD

Blood (2010) 116 (21): 3683.

https://doi.org/10.1182/blood.V116.21.3683.3683

Published: 2010

Journal Articles

Polymorphisms in TNFA and CTLA-4 Genes and the Risk of Heparin Induced Thrombocytopenia.

Dorothee Leroux, Claire Pouplard, PharmD, PhD, Benoit Guillet, MD, PhD, Beatrice Cosne, Marc Antoine May, MD, Yves Gruel, MD

Blood (2008) 112 (11): 3414.

https://doi.org/10.1182/blood.V112.11.3414.3414

Published: 2008

Journal Articles

A New Enzyme Immuno-Assay That Only Detects IgG Antibodies to Heparin-PF4 Complexes (Zymutest HIA IgG®) Improves the Specificity of the Diagnosis of HIT without Loss of Sensitivity.

Claire Pouplard, PharmD, PhD, Sandra Regina, MD, Jean Baptiste Valentin, Yves Gruel, MD

Blood (2007) 110 (11): 2096.

https://doi.org/10.1182/blood.V110.11.2096.2096

Published: 2007

Journal Articles

Prospective Evaluation of 4T’s Score and Rapid Particle Gel Immuno-Assay Specific to H/PF4 Complexes To Exclude Heparin-Induced Thrombocytopenia.

Claire Pouplard, PharmD, Marc Fouassier, MD, Catherine Ternisien, MD, Pierre Gueret, MD, Marc Trossaert, MD, Sandra Regina, MD, Yves Gruel, MD

Blood (2005) 106 (11): 1244.

https://doi.org/10.1182/blood.V106.11.1244.1244

Published: 2005

NARROW

Genome-Wide Association Study Identifies Variation in ABO As Risk Factor for Platelet Reactivity in Heparin-Induced Thrombocytopenia

Is There an Alternative to Serotonin Release Assay for the Diagnosis of Heparin Induced Thrombocytopenia (HIT)? Evaluation of 5 Other Functional Methods Using 5B9 a Monoclonal IgG That Mimics HIT Human Antibodies

Cleavage of Anti-PF4/H IgG Antibodies By Ides, and Potential Benefit in the Treatment of Heparin-Induced Thrombocytopenia

Frequency of Anti-PF4/Heparin Antibodies in Patients Treated with Extra-Corporeal Membrane Oxygenation and Detection By Sensitized Serotonin Release Assay of Pathogenic Heparin-Induced Thrombocytopenia Antibodies

Multicenter Pharmacokinetic Evaluation of rFVIII-Fc (Elocta) in a Real Life and Comparison with Non-Extended Half-Life FVIII Concentrates

Prospective Evaluation of a Rapid Nanoparticle-Based Lateral Flow Immunoassay (Stic Expert HIT ® ) for the Diagnosis of Heparin-Induced Thrombocytopenia

Incidence of Antibodies to Protamine/Heparin Complexes in Cardiac Surgery Patients and Impact on Platelet Activation in Vitro and Clinical Outcome

Interleukin-10 Promoter Microsatellite Polymorphisms Influence the Immune Response to Heparin and the risk of Heparin-Induced Thrombocytopenia.

Influence of Protein Tyrosine Phosphatase Polymorphisms on the Development of Antibodies to Platelet Factor 4 and the Risk of Heparin-Induced Thrombocytopenia.

Polymorphisms in TNFA and CTLA-4 Genes and the Risk of Heparin Induced Thrombocytopenia.

A New Enzyme Immuno-Assay That Only Detects IgG Antibodies to Heparin-PF4 Complexes (Zymutest HIA IgG®) Improves the Specificity of the Diagnosis of HIT without Loss of Sensitivity.

Prospective Evaluation of 4T’s Score and Rapid Particle Gel Immuno-Assay Specific to H/PF4 Complexes To Exclude Heparin-Induced Thrombocytopenia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only